Physician profile
Franklin James
NPI 1659338713
$1,467.14
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $138 · 2021: $372 · 2022: $142 · 2023: $310 · 2024: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.25 | 2021-2024 | |
| Amgen INC. | $174.87 | 2019-2024 | Repatha, Otezla |
| Dexcom, INC. | $155.47 | 2021-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $147.59 | 2021-2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.55 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $122.38 | 2021-2024 | Farxiga |
| Lilly USA, LLC | $100.13 | 2021-2024 | Zepbound, Mounjaro, Jardiance |
| Allergan, INC. | $98.46 | 2019-2020 | |
| Exact Sciences Corporation | $53.75 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.42 | 2024 | |
| Pfizer INC. | $39.58 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $27.05 | 2021 | |
| Janssen Pharmaceuticals, INC | $26.16 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.45 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.